The most clinically important GFs, with a well-grounded long-term impact on remission prevention and the enhancement of overall survival rates of children, especially with ALL, are the granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-stimulating factor (GM-CSF) [23,24]. This evidence concerns the gene CSF2 and acute lymphoblastic leukemia.